These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 25957582
1. Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis. Bielecki B, Jatczak-Pawlik I, Wolinski P, Bednarek A, Glabinski A. Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):367-76. PubMed ID: 25957582 [Abstract] [Full Text] [Related]
2. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Alt C, Laschinger M, Engelhardt B. Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625 [Abstract] [Full Text] [Related]
3. Expression of chemokine receptors CCR7 and CCR8 in the CNS during ChREAE. Bielecki B, Mazurek A, Wolinski P, Glabinski A. Scand J Immunol; 2007 Oct; 66(4):383-92. PubMed ID: 17850582 [Abstract] [Full Text] [Related]
4. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Columba-Cabezas S, Serafini B, Ambrosini E, Aloisi F. Brain Pathol; 2003 Jan; 13(1):38-51. PubMed ID: 12580544 [Abstract] [Full Text] [Related]
5. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. Kuwabara T, Ishikawa F, Yasuda T, Aritomi K, Nakano H, Tanaka Y, Okada Y, Lipp M, Kakiuchi T. J Immunol; 2009 Aug 15; 183(4):2513-21. PubMed ID: 19625643 [Abstract] [Full Text] [Related]
6. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions. Purvanov V, Matti C, Samson GPB, Kindinger I, Legler DF. Int J Mol Sci; 2018 Dec 04; 19(12):. PubMed ID: 30518137 [Abstract] [Full Text] [Related]
7. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation. Fevang B, Yndestad A, Damås JK, Halvorsen B, Holm AM, Beiske K, Aukrust P, Frøland SS. Clin Exp Immunol; 2009 Nov 04; 158(2):237-45. PubMed ID: 19747210 [Abstract] [Full Text] [Related]
8. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC. Tumour Biol; 2013 Feb 04; 34(1):65-70. PubMed ID: 22976543 [Abstract] [Full Text] [Related]
9. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease. Cai W, Tao J, Zhang X, Tian X, Liu T, Feng X, Bai J, Yan C, Han Y. Arterioscler Thromb Vasc Biol; 2014 Sep 04; 34(9):1933-41. PubMed ID: 24990231 [Abstract] [Full Text] [Related]
10. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P. Arterioscler Thromb Vasc Biol; 2007 Mar 04; 27(3):614-20. PubMed ID: 17170367 [Abstract] [Full Text] [Related]
11. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. Wang J, Seethala RR, Zhang Q, Gooding W, van Waes C, Hasegawa H, Ferris RL. J Natl Cancer Inst; 2008 Apr 02; 100(7):502-12. PubMed ID: 18364504 [Abstract] [Full Text] [Related]
12. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis. Tateyama M, Fujihara K, Misu T, Itoyama Y. J Neurol Sci; 2009 Apr 15; 279(1-2):47-52. PubMed ID: 19171354 [Abstract] [Full Text] [Related]
13. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes. Hauser MA, Legler DF. J Leukoc Biol; 2016 Jun 15; 99(6):869-82. PubMed ID: 26729814 [Abstract] [Full Text] [Related]
15. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis. Tateyama M, Fujihara K, Misu T, Feng J, Onodera Y, Itoyama Y. J Neurol Sci; 2006 Nov 15; 249(2):158-65. PubMed ID: 16887149 [Abstract] [Full Text] [Related]
17. The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease. Wang T, Li W, Cheng H, Zhong L, Deng J, Ling S. Ocul Immunol Inflamm; 2021 Feb 17; 29(2):266-277. PubMed ID: 31702421 [Abstract] [Full Text] [Related]
18. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells. Halvorsen B, Dahl TB, Smedbakken LM, Singh A, Michelsen AE, Skjelland M, Krohg-Sørensen K, Russell D, Höpken UE, Lipp M, Damås JK, Holm S, Yndestad A, Biessen EA, Aukrust P. Cardiovasc Res; 2014 Apr 01; 102(1):148-56. PubMed ID: 24518141 [Abstract] [Full Text] [Related]
19. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21. Lee J, Park C, Kim HJ, Lee YD, Lee ZH, Song YW, Kim HH. Exp Mol Med; 2017 Jul 21; 49(7):e358. PubMed ID: 28729639 [Abstract] [Full Text] [Related]
20. ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes. Bryce SA, Wilson RA, Tiplady EM, Asquith DL, Bromley SK, Luster AD, Graham GJ, Nibbs RJ. J Immunol; 2016 Apr 15; 196(8):3341-53. PubMed ID: 26976955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]